Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Jun 2, 2017 at 1:35 PM EDT

15 Companies Bracing for Big ASCO Reactions

24/7 Wall St. takes a look at the ASCO annual meeting each year and picks out the companies that could…

Chris Lange | Jun 1, 2017 at 1:25 PM EDT

Why Minerva Shares Are Climbing

Minerva Neurosciences has amended its co-development agreement with Janssen Pharma will repurchase all of its shares owned by Johnson &…

Trey Thoelcke | Jun 1, 2017 at 7:20 AM EDT

A New Era of Cancer Research as ASCO Kicks Off

Just ahead of the 2017 annual meeting of the American Society of Clinical Oncology, a new report shows that more…

Chris Lange | May 31, 2017 at 12:15 PM EDT

Why Credit Suisse Sees Insurers Gaining More Than Hospitals

Credit Suisse has raised its price targets for select managed care organizations but remains neutral to cautious on hospital stocks.

Jon C. Ogg | May 31, 2017 at 10:40 AM EDT

Why Analysts Think Protagonist Therapeutics Could Still More Than Double After the News

When companies see their shares rise almost 50%, investors probably just assume the news is from a buyout or a…

Jon C. Ogg | May 31, 2017 at 8:55 AM EDT

7 Speculative Biotech and Pharma Stocks That Could Still Double (or More)

Here are seven speculative biotech and biohealth stocks where analysts gave huge upside calls during the month of May 2017.

Jon C. Ogg | May 30, 2017 at 3:20 PM EDT

Can Protagonist Therapeutics Stock Still Double After Its Huge Gain?

Protagonist Therapeutics Inc. (NASDAQ: PTGX) saw its shares move up so much on May 30 that some investors probably just…

Chris Lange | May 30, 2017 at 1:55 PM EDT

ImmunoGen Rises Following Licensing Update With Sanofi

ImmunoGen watched its stock make a handy gain after the firm announced that had amended its license agreements with Sanofi.

Chris Lange | May 30, 2017 at 9:30 AM EDT

Why Protagonist Therapeutics Shares Are Climbing

Protagonist Therapeutics saw its shares make a solid gain early on Tuesday after the company announced a key worldwide licensing…

Chris Lange | May 27, 2017 at 8:40 AM EDT

Can MEI Pharma Rise Nearly 300%?

MEI Pharma, Inc. (NASDAQ: MEIP) saw its shares make a solid gain on Thursday after the company received a crucial…

Lee Jackson | May 25, 2017 at 10:15 AM EDT

Big Pharma Has Big Catalysts Coming for the Rest of 2017

A new Deutsche Bank research report focuses on the big capitalization pharmaceutical stocks and the upcoming catalysts and news flow…

Chris Lange | May 25, 2017 at 9:50 AM EDT

Short Sellers Raise the Stakes in Major Biotechs

The May 15 short interest data have been compared with the previous report, and moves in the selected biotech stocks…

Chris Lange | May 25, 2017 at 9:45 AM EDT

Major Pharma Short Interest Surges

The May 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | May 24, 2017 at 1:55 PM EDT

What to Expect From Eli Lilly at ASCO

24/7 Wall St. takes a look at Eli Lilly, and what Credit Suisse sees happening for this pharma giant at…

1 … 165 166 167 168 169 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

15 Companies Bracing for Big ASCO Reactions

Why Minerva Shares Are Climbing

A New Era of Cancer Research as ASCO Kicks Off

Why Credit Suisse Sees Insurers Gaining More Than Hospitals

Why Analysts Think Protagonist Therapeutics Could Still More Than Double After the News

7 Speculative Biotech and Pharma Stocks That Could Still Double (or More)

Can Protagonist Therapeutics Stock Still Double After Its Huge Gain?

ImmunoGen Rises Following Licensing Update With Sanofi

Why Protagonist Therapeutics Shares Are Climbing

Top Presentations to Look for at ASCO

Can MEI Pharma Rise Nearly 300%?

Big Pharma Has Big Catalysts Coming for the Rest of 2017

Short Sellers Raise the Stakes in Major Biotechs

Major Pharma Short Interest Surges

What to Expect From Eli Lilly at ASCO

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Live Nasdaq Composite: Tech Stock Gains Unleashed as Stars Align for Risk-On Trade

These 4 Dividend Growers Have Already Declared 10% Dividend Increases

Analysts See 118% Upside for Strategy After Bitcoin Crashed 27% in 6 Months

A Bigger 2027 Capex Wave May Be Coming — and Google’s Hint Could Be the First Real Tell From the Hyperscalers

27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income

Seven Out of Every Ten Dollars of Americans $18.8 Trillion Debt Is Tied To A House

These 4 Dividend Growers Have Already Declared 10% Dividend Increases

Analysts See 118% Upside for Strategy After Bitcoin Crashed 27% in 6 Months

Health and Healthcare Articles

All Health and Healthcare Articles

15 Companies Bracing for Big ASCO Reactions

Why Minerva Shares Are Climbing

A New Era of Cancer Research as ASCO Kicks Off

Why Credit Suisse Sees Insurers Gaining More Than Hospitals

Why Analysts Think Protagonist Therapeutics Could Still More Than Double After the News

7 Speculative Biotech and Pharma Stocks That Could Still Double (or More)

Can Protagonist Therapeutics Stock Still Double After Its Huge Gain?

ImmunoGen Rises Following Licensing Update With Sanofi

Why Protagonist Therapeutics Shares Are Climbing

Top Presentations to Look for at ASCO

Can MEI Pharma Rise Nearly 300%?

Big Pharma Has Big Catalysts Coming for the Rest of 2017

Short Sellers Raise the Stakes in Major Biotechs

Major Pharma Short Interest Surges

What to Expect From Eli Lilly at ASCO

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Live Nasdaq Composite: Tech Stock Gains Unleashed as Stars Align for Risk-On Trade

These 4 Dividend Growers Have Already Declared 10% Dividend Increases

Analysts See 118% Upside for Strategy After Bitcoin Crashed 27% in 6 Months

A Bigger 2027 Capex Wave May Be Coming — and Google’s Hint Could Be the First Real Tell From the Hyperscalers

Featured Reads

27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income

Seven Out of Every Ten Dollars of Americans $18.8 Trillion Debt Is Tied To A House